Synthetic cannabinoid-induced anxiety disorder

Synthetic cannabinoid-induced anxiety disorder is characterized by anxiety symptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive autonomic arousal, avoidance behavior) that develop during or soon after intoxication with or withdrawal from synthetic cannabinoids. The intensity or duration of the symptoms is substantially in excess of anxiety symptoms that are characteristic of Synthetic cannabinoid intoxication or Synthetic cannabinoid withdrawal. The amount and duration of synthetic cannabinoid use must be capable of producing anxiety symptoms. The symptoms are not better explained by a primary mental disorder (e.g., an Anxiety and Fear-Related Disorder, a Depressive Disorder with prominent anxiety symptoms), as might be the case if the anxiety symptoms preceded the onset of the synthetic cannabinoid use, if the symptoms persist for a substantial period of time after cessation of the synthetic cannabinoid use or withdrawal, or if there is other evidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a history of prior episodes not associated with synthetic cannabinoid use).

ICD-11 diagnostic criteria

• objawy lękowe
• związek z używaniem substancji

How to recognise

In the ICD-11 framework, the core symptoms taken into account when recognising Synthetic cannabinoid-induced anxiety disorder are:

• nasilony niepokój

Differential diagnosis

When diagnosing Synthetic cannabinoid-induced anxiety disorder, the following ICD-11 disorders should be considered in the differential diagnosis:

• Zaburzenia związane z używaniem kannabinoidów pochodzenia roślinnego (6C41)

Frequently asked questions

How is Synthetic cannabinoid-induced anxiety disorder diagnosed according to ICD-11?

According to ICD-11, the diagnostic criteria for Synthetic cannabinoid-induced anxiety disorder (6C42.71) include: objawy lękowe; związek z używaniem substancji.

What disorders are in the differential diagnosis of Synthetic cannabinoid-induced anxiety disorder?

The differential diagnosis of Synthetic cannabinoid-induced anxiety disorder (6C42.71) includes: Zaburzenia związane z używaniem kannabinoidów pochodzenia roślinnego (6C41).

WHO ICD-11 source

View this entry in the official WHO ICD-11 browser: 6C42.71 – WHO ICD-11

Notes

Proszę zakodować również jednostkę chorobową (schorzenie) będące przyczyną